Compounds > lapatinib
Page last updated: 2024-09-05

lapatinib and pseudolaric acid b

lapatinib has been researched along with pseudolaric acid b in 1 studies

Compound Research Comparison

Studies
(lapatinib)		Trials
(lapatinib)		Recent Studies (post-2010)
(lapatinib)		Studies
(pseudolaric acid b)		Trials
(pseudolaric acid b)		Recent Studies (post-2010) (pseudolaric acid b)
1,9193051,44295058

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cheng, N; Ding, D; Jiang, M; Li, W; Lou, H; Miao, Y; Sheng, H; Wu, X; Zhang, W; Zhao, L1

Other Studies

1 other study(ies) available for lapatinib and pseudolaric acid b

ArticleYear
Co-loaded lapatinib/PAB by ferritin nanoparticles eliminated ECM-detached cluster cells via modulating EGFR in triple-negative breast cancer.
    Cell death & disease, 2022, 06-20, Volume: 13, Issue:6

    Topics: Cell Line, Tumor; Diterpenes; ErbB Receptors; Ferritins; Humans; Lapatinib; Nanoparticles; Neoplasm Recurrence, Local; Triple Negative Breast Neoplasms

2022